Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025811 · ClinicalTrials.gov registry record · Phase 4

A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

A Phase 4 study of Dry Eye Disease, sponsored by Hoffmann-La Roche.

Recruiting
Registry status
Phase 4
Development phase
350
Enrollment target
5
Study locations

NCT07025811 is a Phase 4 study of Dry Eye Disease that is actively recruiting participants, run by Hoffmann-La Roche. The registered enrollment target is 350 participants, above the 244-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (43% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025811, a Phase 4 study of Dry Eye Disease, is actively recruiting participants, sponsored by Hoffmann-La Roche.

RECRUITING
Registry status
Phase 4
Development phase
350 participants
Enrollment target
5
Study locations

Study Summary

This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).

Conditions Studied

Dry Eye Disease

Interventions

  • DRUG Vevye®
  • DRUG Xiidra®

Study Locations (5)

Kentucky

  • Butchertown Clinical Trials - Louisville

Massachusetts

  • Andover Eye Associates - Andover

North Carolina

  • Oculus Research - Garner

Tennessee

  • Total Eyecare, P.A. - Memphis

Virginia

  • Piedmont Eye Center - Lynchburg

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2025-07-09
Est. Completion 2026-04-30
Phase Phase 4

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07025811

The ClinicalTrials.gov registry entry for NCT07025811 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 244-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (43% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 2 interventions - of which Vevye® is the first listed.

NCT07025811 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Kentucky, Massachusetts, North Carolina.

Frequently Asked Questions

What is clinical trial NCT07025811 about?

NCT07025811 is a clinical study titled "A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment". This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).

What is the current status of trial NCT07025811?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2025-07-09. Estimated completion is 2026-04-30.

What conditions does trial NCT07025811 study?

This clinical trial studies the following conditions: Dry Eye Disease.

What interventions are being tested in trial NCT07025811?

The interventions under investigation include: Vevye® (DRUG), Xiidra® (DRUG).

Who is sponsoring clinical trial NCT07025811?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025811 being conducted?

This trial has 5 study locations across Kentucky, Massachusetts, North Carolina, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye Disease

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.